MANNATECH INC

MTEX

MANNATECH INC

MTEX

Insider Sentiment (TTM):

Last Purchase:2026-05-20Last Sale:2024-09-09Shares Purchased (TTM):14,903Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:177,657Shares Outstanding:1,929,000Institutional Ownership Pct.:9.21%

Earnings Market Reaction:

Filing Date:2026-08-12Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Cash And Cash Equivalents At Carrying Value	6	7	6	7	9	11	12	9	8	8	8
Restricted Cash And Cash Equivalents At Carrying V…	0	0	1	1	1	1	1	1	1	1	1
Accounts Receivable Net Current	0	0	0	0	0	0	0	0	0	0	0
Income Taxes Receivable	0	0	1	1	1	1	0	0	0	0	0
Inventory Net	10	10	10	11	12	10	12	13	14	15	15
Prepaid Expense And Other Assets Current	2	2	2	2	3	2	2	2	3	2	2
Capitalized Contract Cost Net Current	-	-	-	-	-	-	-	2	2	-	2
Deferred Sales Commission	-	-	-	-	1	-	1	-	2	-	2
Assets Current	19	21	21	22	27	26	29	28	28	28	29
Property Plant And Equipment Net	-	-	2	3	-	3	-	-	-	4	-
Operating Lease Right Of Use Asset	3	3	3	4	2	2	3	3	-	3	-
Other Assets Noncurrent	3	3	3	3	3	3	4	4	7	4	7
Construction In Progress Gross	-	-	-	-	-	-	-	-	-	0	-
Deferred Income Tax Assets Net	-	-	0	2	2	2	2	2	2	2	1
Capital Lease Obligations Current	-	-	-	-	-	0	-	-	0	0	0
Restricted Cash Noncurrent	0	0	0	0	1	1	1	1	1	1	1
Assets	27	30	30	34	37	36	41	40	41	41	42
Deferred Tax Assets Liabilities Net	-	-	-	-	-	-	-	-	-	2	-
Accrued Liabilities Current	3	3	3	3	4	4	5	6	6	5	8
Deferred Revenue Current	-	-	-	-	-	3	-	-	-	5	-
Deferred Revenue	-	-	-	-	2	-	3	4	4	-	4
Contract With Customer Liability Current	2	3	3	2	-	3	-	-	4	-	4
Accounts Payable Current	4	3	2	4	4	2	4	3	5	4	4
Operating Lease Liability Current	2	2	2	2	1	1	2	-	-	2	-
Taxes Payable Current	1	1	1	1	2	2	1	2	2	2	1
Notes Payable Current	0	0	0	0	0	0	0	0	1	0	0
Finance Lease Liability Current	-	0	0	0	0	0	0	0	-	-	-
Liabilities Current	17	19	19	20	23	21	23	24	26	26	26
Capital Lease Obligations Noncurrent	-	-	-	-	-	-	-	-	1	1	1
Long Term Notes Payable	3	3	3	3	3	3	4	4	-	0	-
Operating Lease Liability Noncurrent	1	2	2	3	2	2	2	2	-	3	-
Other Liabilities Noncurrent	1	1	1	1	1	1	1	1	4	1	4
Finance Lease Liability Noncurrent	-	0	0	0	1	1	1	1	-	1	-
Deferred Income Tax Liabilities Net	10	10	10	-	-	0	-	-	-	-	-
Liabilities	32	35	35	27	29	27	31	32	31	31	32
Commitments And Contingencies	-	-	-	-	-	-	-	-	0	-	-
Stockholders Equity
Preferred Stock Value	0	0	0	0	0	0	0	0	0	0	0
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	33	33	33	33	33	33	33	33	33	33	33
Retained Earnings Accumulated Deficit	-12	-13	-14	-3	-0	1	-1	-1	-0	-1	0
Accumulated Other Comprehensive Income Loss Net Of…	-7	-6	-5	-4	-5	-6	-2	-4	-2	-1	-3
Treasury Stock Value	-	-	-	-	-20	-20	-20	-20	-20	-21	-21
Treasury Stock Common Value	-19	-19	-20	-20	-	-20	-	-	-	-	-
Stockholders Equity	-5	-6	-5	7	8	9	10	8	10	10	11
Liabilities And Stockholders Equity	27	30	30	34	37	36	41	40	41	41	42
Allowance For Doubtful Accounts Receivable Current	0	1	1	1	1	1	1	1	1	1	1
Preferred Stock Par Or Stated Value Per Share	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
Liabilities And Stockhold…
Preferred Stock Shares Authorized	1	1	1	1	1	1	1	1	1	1	1
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0
Common Stock Shares Authorized	99	99	99	99	99	99	99	99	99	99	99
Common Stock Shares Issued	3	3	3	3	3	3	3	3	3	3	3
Shares Outstanding	2	2	2	2	2	2	2	2	2	2	2
Treasury Stock Common Shares	1	1	1	1	1	1	1	1	1	1	1

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	23.38%	11.69%	5.63%	-	-	-	-	-	-	-	-	-
2025	-9.50%	-21.97%	-30.45%	-	-	-	1.37%	-12.20%	-21.66%	14.92%	14.92%	4.03%
2024	4.73%	-0.14%	-5.41%	4.44%	2.08%	8.61%	46.80%	96.40%	55.07%	5.56%	17.22%	4.44%
2023	-	-	-	-17.57%	-29.02%	-38.44%	-2.62%	-7.74%	11.05%	1.34%	-3.28%	-2.92%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	1.15	1.09	1.10	1.13	1.18	1.25	1.25	1.17	1.08	1.07	1.09
Quick Ratio	0.46	0.46	0.47	0.48	0.51	0.67	0.64	0.52	0.44	0.44	0.43
Working Capital	2.55M	1.73M	1.84M	2.58M	3.97M	5.23M	5.75M	3.97M	2.13M	1.88M	2.27M
Leverage & Debt
Debt to Equity	-6.53	-6.38	-6.74	3.88	3.83	3.19	3.06	3.87	2.93	2.93	2.94
Interest Coverage TTM	2.21	-1.19	0.76	6.42	-0.49	3.55	-1.38	-7.12	-16.48	-16.62	-33.16
Debt Ratio	1.18	1.19	1.17	0.80	0.79	0.76	0.75	0.79	0.75	0.75	0.75
Efficiency & Turnover
Asset Turnover TTM	4.15	4.03	3.88	3.15	2.96	3.05	2.94	2.87	2.77	2.92	2.82
Days Sales Outstanding TTM	0.33	0.04	0.03	0.21	0.67	0.17	0.26	1.11	0.65	0.43	0.57
Receivables Turnover TTM	1,113.32	9,169.31	11,917.04	1,700.10	545.19	2,143.02	1,421.66	328.98	561.74	854.08	637.69
Per Share Metrics
Diluted EPS TTM	-6.07	-7.39	-6.81	1.22	-0.12	1.32	-0.81	-0.63	-0.88	-1.20	-3.75
Free Cash Flow Per Share TTM	-2.14	-2.68	-3.42	-1.59	-1.01	0.93	0.29	-1.25	-1.35	-1.67	-2.59
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.20	0.40	0.40
Margin Metrics
Gross Profit Margin TTM	75.59%	75.08%	76.12%	76.42%	76.58%	77.60%	76.30%	77.67%	78.01%	77.95%	76.29%
Operating Profit Margin TTM	0.92%	-0.46%	0.32%	2.51%	-0.19%	1.21%	-0.27%	-0.85%	-0.67%	-0.73%	-2.04%
Net Profit Margin TTM	-8.81%	-10.73%	-9.45%	2.00%	-0.19%	2.11%	-1.26%	-0.97%	-1.31%	-1.70%	-5.23%
Growth Metrics
Net Revenue Growth (1Y)	15.65%	12.80%	12.75%	-4.84%	-9.59%	-10.68%	-9.02%	-10.38%	-8.42%	-3.83%	-6.16%
Net Income Growth (1Y)	5,226.36%	-672.81%	747.58%	-296.95%	-86.77%	-211.21%	-78.15%	-79.69%	-58.63%	-50.13%	-251.74%
EPS Growth (1Y)	5,146.33%	-659.75%	740.44%	-295.30%	-86.89%	-210.09%	-78.40%	-79.85%	-58.90%	-48.88%	-255.24%
Valuation Metrics
P/E TTM	-0.86	-0.78	-1.21	8.12	-79.32	10.17	-9.56	-10.83	-9.31	-6.75	-2.76
P/B TTM	-2.02	-2.01	-3.00	2.72	2.30	2.94	1.46	1.56	1.48	1.44	1.80
P/S TTM	0.08	0.08	0.11	0.16	0.15	0.21	0.12	0.10	0.12	0.11	0.14
Market Cap	10.06M	11.15M	15.68M	18.91M	17.45M	25.32M	14.61M	12.80M	15.49M	15.11M	19.28M
Enterprise Value	7.04M	7.87M	12.15M	15.42M	10.80M	18.13M	5.71M	7.05M	7.62M	8.15M	11.19M
Calculated Values
Free Cash Flow TTM	-4.12M	-5.18M	-6.50M	-3.02M	-1.92M	1.75M	548.00K	-2.36M	-2.55M	-3.12M	-4.82M
Net Debt	-3.02M	-3.28M	-3.54M	-3.49M	-6.66M	-7.18M	-8.89M	-5.75M	-7.86M	-6.97M	-8.09M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-05-20Purchase

Owner: Jobe, Larry A

Title: -

Shares: 2,803

Price/Share: $4.12

Value: $11,548.36

Shares Owned: 70,000

Relationship: Director

Ownership: Direct

2026-05-19Purchase

Owner: Robbins, Kevin Andrew

Title: -

Shares: 7,100

Price/Share: $4.17

Value: $29,607.00

Shares Owned: 33,333

Relationship: Director

Ownership: Direct

2026-05-19Purchase

Owner: Jobe, Larry A

Title: -

Shares: 5,000

Price/Share: $4.20

Value: $21,000.00

Shares Owned: 67,197

Relationship: Director

Ownership: Direct

2024-09-09Sale

Owner: Jobe, Larry A

Title: -

Shares: 16,288

Price/Share: $7.75

Value: $126,232.00

Shares Owned: 54,721

Relationship: Director

Ownership: Direct

2024-09-09Purchase

Owner: Rameson, Tyler

Title: -

Shares: 16,288

Price/Share: $7.75

Value: $126,232.00

Shares Owned: 299,197

Relationship: Director

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-05-20	Jobe, Larry A	Director	-	Direct	Purchase	2,803	4.12	$11,548.36	70,000	4
2026-05-19	Robbins, Kevin Andrew	Director	-	Direct	Purchase	7,100	4.17	$29,607.00	33,333	4
2026-05-19	Jobe, Larry A	Director	-	Direct	Purchase	5,000	4.20	$21,000.00	67,197	4
2024-09-09	Jobe, Larry A	Director	-	Direct	Sale	16,288	7.75	$126,232.00	54,721	4
2024-09-09	Rameson, Tyler	Director	-	Direct	Purchase	16,288	7.75	$126,232.00	299,197	4
2024-05-22	Jobe, Larry A	Director	-	Direct	Sale	1,012	7.60	$7,691.20	71,009	4
2023-08-30	Bala, Alfredo	Officer	CEO and President	Direct	Sale	1,000	12.40	$12,400.00	3,137	4
2023-08-18	Jobe, Larry A	Director	-	Direct	Sale	1,217	12.82	$15,601.94	67,089	4
2023-06-30	Bala, Alfredo	Officer	CEO and President	Direct	Sale	115	12.62	$1,451.30	4,137	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

9.21%

Inst. Shares: 177,657

Shares Outstanding: 1,929,000

2025-12-31

10.51%

Inst. Shares: 199,781

Shares Outstanding: 1,901,000

2025-09-30

11.00%

Inst. Shares: 209,095

Shares Outstanding: 1,901,000

2025-06-30

10.87%

Inst. Shares: 206,642

Shares Outstanding: 1,901,000

2025-03-31

10.85%

Inst. Shares: 206,328

Shares Outstanding: 1,901,000

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	177,657	1,929,000	9.21%
2025-12-31	199,781	1,901,000	10.51%
2025-09-30	209,095	1,901,000	11.00%
2025-06-30	206,642	1,901,000	10.87%
2025-03-31	206,328	1,901,000	10.85%
2024-12-31	186,903	1,885,000	9.92%
2024-09-30	195,648	1,885,000	10.38%
2024-06-30	193,733	1,885,000	10.28%
2024-03-31	158,797	1,884,000	8.43%
2023-12-31	158,358	1,866,000	8.49%
2023-09-30	352,688	1,863,000	18.93%
2023-06-30	367,282	1,870,000	19.64%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

MANNATECH INC (MTEX) — SEC Financial Statements & Analysis

MANNATECH INC (MTEX) is a medicinal chemicals & botanical products company, incorporated in TX. MANNATECH INC trades on Nasdaq as: MTEX. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), MANNATECH INC reported a 15.65% year-over-year revenue growth, a Gross Profit Margin of 75.59% (TTM), a Debt-to-Equity ratio of -6.53x, a Price-to-Sales (P/S) ratio of 0.08x (TTM), a Price-to-Book (P/B) ratio of -2.02x (TTM), at a market cap of $10.06M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 15.65%
Gross Profit Margin TTM: 75.59%
Debt To Equity: -6.53x
P/S TTM: 0.08x
P/B TTM: -2.02x
Market Cap: $10.06M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is MANNATECH INC in?

MANNATECH INC (MTEX) operates in the Medicinal Chemicals & Botanical Products industry.

What is MTEX's market cap?

MANNATECH INC (MTEX) has a market capitalization of $10.06M as of 2026-06-30.

What exchange does MTEX trade on?

MANNATECH INC (MTEX) trades on the Nasdaq.

Where is MANNATECH INC incorporated?

MANNATECH INC is incorporated in TX.

MANNATECH INC

Financial Statements

Custom Table

Interactive Financial Visualizations

Earnings Market Reaction

Performance and Valuation Metrics

Insider Transactions

Institutional Ownership

MANNATECH INC (MTEX) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Medicinal Chemicals & Botanical Products

Wall Street's data.
Main Street's price.

MANNATECH INC (MTEX) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Medicinal Chemicals & Botanical Products

Wall Street's data.Main Street's price.

Wall Street's data.
Main Street's price.